Skip to main content
SpringerLink
Log in
Book cover

Encyclopedia of Cancer pp 1–7Cite as

Neuroendocrine Carcinoma

  • Living reference work entry
  • First Online:

  • 50 Accesses

Synonyms

Apudomas; Carcinoid tumors; Islet cell tumors; Malignant endocrine tumors; Neuroendocrine tumors of the pancreas

Definition

Neuroendocrine carcinomas are tumors derived from the diffuse neuroendocrine system.

Characteristics

Neuroendocrine carcinomas will include a heterogeneous group of tumors that can arise wherever the diffuse neuroendocrine system is found throughout the body.

Classification

It is widely accepted to divide these malignancies in two major groups: carcinoid tumors and neuroendocrine tumors of the pancreas. There are other, rare malignancies that also are classified as neuroendocrine carcinomas, including pheochromocytomas, medullary thyroid carcinoma, and Merkel cell tumors.

Other subclassifications will consider these tumors according to site of origin (lung, gastrointestinal tract, etc.), capability of producing certain hormones (functioning and nonfunctioning tumors), degree of cellular differentiation as an indicator of biological aggressiveness (well,...

This is a preview of subscription content, log in via an institution.

References

  • Duran I, Salazar R, Casanovas O et al (2007) New drug development in digestive neuroendocrine tumors. Ann Oncol 18(8):1307–1313

    Article  CAS  PubMed  Google Scholar 

  • Modlin IM, Lye KD, Kidd M (2003) A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97:934–959

    Article  PubMed  Google Scholar 

  • Oberg K (1998) Carcinoid tumors: current concepts in diagnosis and treatment. Oncologist 3:339–345

    Google Scholar 

  • Oberg K (2004) Management of neuroendocrine tumors. Ann Oncol 15(Suppl 4):293–298

    Google Scholar 

  • Robertson RG, Geiger WJ, Davis NB (2006) Carcinoid tumors. Am Fam Physician 74:429–434

    PubMed  Google Scholar 

See Also

  • (2012) Antiangiogenic. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 207. doi:10.1007/978-3-642-16483-5_310

    Google Scholar 

  • (2012) Chemoembolization. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 772. doi:10.1007/978-3-642-16483-5_1065

    Google Scholar 

  • (2012) Chromogranin A. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 834. doi:10.1007/978-3-642-16483-5_1135

    Google Scholar 

  • (2012) Diffuse Neuroendocrine System. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1116. doi:10.1007/978-3-642-16483-5_1619

    Google Scholar 

  • (2012) Embolization. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1220. doi:10.1007/978-3-642-16483-5_1856

    Google Scholar 

  • (2012) Glucagonoma. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1558. doi:10.1007/978-3-642-16483-5_2428

    Google Scholar 

  • (2012) 5-HydroxyIndoleacetic Acid. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1779. doi:10.1007/978-3-642-16483-5_2892

    Google Scholar 

  • (2012) Interferon. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1888. doi:10.1007/978-3-642-16483-5_3090

    Google Scholar 

  • (2012) Medullary Thyroid Carcinoma. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, pp 2199–2200. doi:10.1007/978-3-642-16483-5_3600

    Google Scholar 

  • (2012) MTOR. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2384. doi:10.1007/978-3-642-16483-5_3867

    Google Scholar 

  • (2012) Octreotide. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2597. doi:10.1007/978-3-642-16483-5_4190

    Google Scholar 

  • (2012) Palliative. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2759. doi:10.1007/978-3-642-16483-5_4350

    Google Scholar 

  • (2012) Somatostatinoma. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3470. doi:10.1007/978-3-642-16483-5_5416

    Google Scholar 

  • (2012) Somatostatin Receptor Scintigraphy. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3470. doi:10.1007/978-3-642-16483-5_5415

    Google Scholar 

  • (2012) Sunitinib. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3562. doi:10.1007/978-3-642-16483-5_5575

    Google Scholar 

  • (2012) VIPoma. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3908. doi:10.1007/978-3-642-16483-5_6190

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology and Hematology, Robert and Maggie Bras and Family New Drug Development Program, Princess Margaret Hospital, Toronto, ON, Canada

    Ignacio Duran & Lillian L. Siu

Authors
  1. Ignacio Duran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lillian L. Siu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ignacio Duran .

Editor information

Editors and Affiliations

  1. Abt. Tumorgenetik, Deutsches Krebsforschungszentrum, Heidelberg, Germany

    Manfred Schwab

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Duran, I., Siu, L.L. (2014). Neuroendocrine Carcinoma. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_4029-4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27841-9_4029-4

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27841-9

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics

Search

Navigation